Loading organizations...
§ Private Profile · New York City, NY, USA
Vaginal health platform offering at-home vaginal microbiome tests and personalized care for women, focused on closing the gender health gap.
Based in New York, New York, Evvy is a direct-to-consumer healthcare company that provides at-home vaginal microbiome testing and precision care services utilizing metagenomic sequencing. The organization operates a digital health platform combining diagnostic testing with personalized recommendations to track female biomarkers and build large-scale clinical datasets. By analyzing these overlooked aspects of women's health, the business aims to close existing gender health gaps through proprietary research and targeted medical insights. Operating with a core team of approximately ten employees, the enterprise has processed diagnostic tests for a community of over 10,000 active users. Evvy has raised more than $6.5 million in total venture funding, securing financial backing from prominent institutional investors including General Catalyst, Box Group, and BBG Ventures. The company was founded in 2021 by Priyanka Jain, Laine Bruzek, and Pita Navarro.
Evvy has raised $19.0M across 2 funding rounds.
Evvy has raised $19.0M in total across 2 funding rounds.
Evvy has raised $19.0M across 2 funding rounds. Most recently, it raised $14.0M Series A in September 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 27, 2023 | $14M Series A | Laura Sillman | Amboy Street Ventures, G9 Ventures, General Catalyst, Ingeborg Investments, Labcorp, RH Capital, Virtue | Announced |
| Jul 14, 2021 | $5M Seed | Margaret Georgiadis | — | Announced |
Evvy has raised $19.0M in total across 2 funding rounds.
Evvy's investors include Laura Sillman, Amboy Street Ventures, G9 Ventures, General Catalyst, Ingeborg Investments, Labcorp, RH Capital, Virtue, Margaret Georgiadis.